Hargreaves Lansdown

Aptamer signs second Optimer programme contract with Unilever

Fri 30 May 2025 09:42 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with global consumer goods leader, Unilever.

Aptamer stated that under the new agreement, it will develop a novel panel of Optimer binders targeting an additional biological pathway associated with body odour formation, potentially providing Unilever with a second strategy to prevent the formation of body malodour.

The AIM-listed group said the agreement was structured on a fee-for-service basis, with Aptamer receiving an undisclosed six-figure sum for the development work. On-person performance trials were anticipated to take place before the end of 2025.

Chief executive Arron Tolley said: "I am excited by the additional project we are undertaking with Unilever. This project expands our partnership with Unilever in the odour control space. The excellent results produced by our team in the first project have resulted in a deepening partnership with Unilever, expanding on the applicability of our Optimer binders.

"The first project is now moving toward on-person trials, and this deal positions us well to create multiple, licensable assets with a global powerhouse in the consumer health market. This second programme reflects the confidence Unilever has in the Optimer platform and the significant value we can unlock by expanding our offering into novel, large-scale applications like personal care."

As of 1025 BST, Aptamer shares were up 11.76% at 0.38p.

Reporting by Iain Gilbert at Sharecast.com

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More AIM news from ShareCast

    No results were found